Vitae Biomedical participated in the BIO Asia-Taiwan 2022, targeting people at high risk of lung cancer. The Lung Cancer IVD Reagent shows high accuracy and can help doctors make more effective diagnoses.

“Australia-Taiwan Biotech Collaboration Forum” was also held during BIO Asia-Taiwan. Vitae Biomedical was invited to participate in this conference for its research and development achievements in precision medicine assisted diagnosis, and will represent Taiwan in discussions with Australian medical institutions and the biopharmaceutical industry.

During BIO Asia-Taiwan, Dr. I-Shu Lee, general manager of Vitae Biomedical will also give talks on the stage of the National Biotechnology Research Park exhibition area, and take photos with visiting former Vice President Chen Chien-jen.

Source URL：https://expo.bioasiataiwan.com/en/visitorExNewsDetail.asp?id=10204
Media：BIO Asia-Taiwan Website